Stay updated on Efficacy of Pexidartinib in TGCT Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Pexidartinib in TGCT Clinical Trial page.

Latest updates to the Efficacy of Pexidartinib in TGCT Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded Tenosynovial giant cell tumor, diffuse type as a terminology item and a Genetic and Rare Diseases Information Center resource to the study page.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check30 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check58 days agoChange DetectedAdministrative site changes include addition of Revision v3.4.2 and removal of the funding-status notice and Revision v3.4.1, which do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check65 days agoChange DetectedNotice about a lapse in government funding and NIH status update has been added, and the page revision has been updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check72 days agoChange DetectedThe page adds a glossary toggle, introduces Last Update Submitted that Met QC Criteria and Last Update Posted fields, shows No FEAR Act Data, and updates the revision to v3.4.0, while removing older metadata items such as Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and revision v3.3.4.SummaryDifference0.3%

Stay in the know with updates to Efficacy of Pexidartinib in TGCT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Pexidartinib in TGCT Clinical Trial page.